Medicine and Dentistry
Clinical Trial
100%
Neoplasm
74%
Oncology
66%
Cyclophosphamide
45%
Carcinoma
41%
Disease
39%
Survival Time
36%
Malignant Neoplasm
36%
Uterine Cervix Carcinoma
33%
Radiation Therapy
33%
Altretamine
30%
Osteosarcoma
30%
Doxorubicin
30%
Ovarian Cancer
28%
Krukenberg Tumor
24%
Metastatic Carcinoma
23%
Adverse Event
22%
Langerhans Cell Histiocytosis
20%
Melphalan
18%
Vincristine
18%
Laparotomy
18%
Central Nervous System
18%
Clinician
18%
Prostate Cancer
15%
Disease Free Survival
15%
Testes
14%
Squamous Cell Carcinoma
13%
Cohort Effect
13%
Cancer Therapy
13%
Cervix
13%
Meta-Analysis
12%
Placebo
12%
Recurrent Disease
12%
Acute Leukemia
12%
Leukemia
12%
Acute Lymphoblastic Leukemia
12%
Necrosis
12%
Tumor Immunology
10%
Hyperalimentation
10%
Long Term Survival
10%
Patient Registration
10%
Tissue Antigen
10%
Cisplatin
10%
Randomized Clinical Trial
10%
Radiation Necrosis
10%
Endodermal Sinus Tumor
10%
Cancer Recurrence
10%
Prostate Carcinoma
10%
Bleomycin
10%
Gonorrhea
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
96%
Malignant Neoplasm
47%
Ovary Cancer
45%
Neoplasm
41%
Remission
39%
Altretamine
36%
Cyclophosphamide
36%
Chemotherapy
34%
Vincristine
32%
Methotrexate
32%
Cisplatin
30%
Trastuzumab
30%
Adverse Event
28%
Survival Time
28%
Prednisone
27%
Prostate Cancer
25%
Doxorubicin
24%
Recurrent Disease
22%
Randomized Clinical Trial
22%
Metastatic Breast Cancer
20%
Vulva Carcinoma
20%
Acute Lymphoblastic Leukemia
20%
Prostate Carcinoma
20%
Gonorrhea
20%
Disease
19%
Placebo
17%
Carcinoma
16%
Squamous Cell Carcinoma
16%
Ovary Carcinoma
16%
Drug Safety
15%
Biosimilar Agent
15%
Melphalan
14%
Osteosarcoma
13%
Immunotherapy
13%
Progression Free Survival
12%
Overall Survival
12%
Mortality Rate
11%
Toxoplasma gondii
10%
Beta Interferon
10%
Life Table
10%
Phosphotyrosine
10%
Prednisolone
10%
Yolk Sac Tumor
10%
Sickle Cell Trait
10%
Mood Disorder
10%
Endometrium Cancer
10%
Mouse
10%
Infection
10%
Epidemiology
10%
Bipolar Disorder
10%
Keyphrases
Hexamethylmelamine
46%
Clinical Trials
42%
Cyclophosphamide
41%
Group Studies
41%
Survival Time
40%
Southwest Oncology Group
40%
Cervical Carcinoma
40%
Osteosarcoma
36%
Adriamycin
32%
Radiation Therapy
30%
Gonorrhea
30%
Chemotherapy
26%
Melphalan
24%
Data Monitoring Committee
22%
Advanced Ovarian Cancer
22%
Methotrexate
22%
Response Rate
20%
Vulvar Squamous Cell Carcinoma
20%
Safety Monitoring
20%
Childhood Acute Lymphoblastic Leukemia
20%
Trastuzumab
20%
Prostatic Carcinoma
20%
Histiocytosis X
20%
Virus
20%
Cis-platinum
20%
Metastasis
20%
Prostatic Cancer
20%
Laparotomy
20%
Ovarian Cancer
19%
Remission
18%
Prednisone
17%
Acute Lymphoblastic Leukemia
16%
Phase II Trial
15%
Tumor
15%
Recurrence Rate
15%
Disease-free Survival
15%
Washington DC
15%
Bone Marrow
15%
In Cancer
15%
Testicle
14%
Prognostic Groups
13%
Radiotherapy
13%
Long-term Survival
13%
Central Nervous System
13%
Safety Concerns
12%
Immune Response
12%
Surgery Alone
12%
Ovarian Carcinoma
12%
Incidence Rate
12%
Prospective Randomized Clinical Trial
12%